-
181
S1 Fig -
Published 2024“…In this article, we introduce a mathematical framework for exploring (i) whether a one-time release of <i>Wolbachia</i> carriers can elicit a sustained presence of carriers near the release site, and (ii) the extent to which spatial propagation of carriers may allow them to establish fixation in other territories. …”
-
182
S2 Fig -
Published 2024“…In this article, we introduce a mathematical framework for exploring (i) whether a one-time release of <i>Wolbachia</i> carriers can elicit a sustained presence of carriers near the release site, and (ii) the extent to which spatial propagation of carriers may allow them to establish fixation in other territories. …”
-
183
Estimating <i>m</i> from a probability density function.
Published 2024“…In this article, we introduce a mathematical framework for exploring (i) whether a one-time release of <i>Wolbachia</i> carriers can elicit a sustained presence of carriers near the release site, and (ii) the extent to which spatial propagation of carriers may allow them to establish fixation in other territories. …”
-
184
-
185
Antidiabetic drugs expenditure.
Published 2025“…Most novel non-insulin antidiabetic products such as empagloflozin, sitagliptin and extended-release metformin were unaffordable during the study period. …”
-
186
Antidiabetic drugs cost per DDD.
Published 2025“…Most novel non-insulin antidiabetic products such as empagloflozin, sitagliptin and extended-release metformin were unaffordable during the study period. …”
-
187
Affordability of insulin analogues.
Published 2025“…Most novel non-insulin antidiabetic products such as empagloflozin, sitagliptin and extended-release metformin were unaffordable during the study period. …”
-
188
Antidiabetic drug utilization.
Published 2025“…Most novel non-insulin antidiabetic products such as empagloflozin, sitagliptin and extended-release metformin were unaffordable during the study period. …”
-
189
Affordability of human insulin.
Published 2025“…Most novel non-insulin antidiabetic products such as empagloflozin, sitagliptin and extended-release metformin were unaffordable during the study period. …”
-
190
Nanocatalase-Based Oxygen-Generating Nanocarriers for Active Oxygen Delivery to Relieve Hypoxia in Pancreatic Cancer
Published 2022“…Hypoxia of the tumor microenvironment has the potential to give rise to significant radiation and drug resistance that can contribute to tumor recurrence and or low treatment efficacy. …”
-
191
In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics
Published 2025“…Transcriptomic analysis verified ferroptosis as the primary cell death mechanism, with significant dysregulation of iron/lipid metabolism pathways. …”
-
192
In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics
Published 2025“…Transcriptomic analysis verified ferroptosis as the primary cell death mechanism, with significant dysregulation of iron/lipid metabolism pathways. …”
-
193
-
194
-
195
-
196
Raw data of Figs 1–6 in this study.
Published 2025“…When gut epithelial PGAM5 receptor and apoptosis were inhibited by PGAM5-specific siRNA, inhibitor (LFHP-1c) and apoptosis inhibitor (Z-VAD-FMK), trans-epithelial electrical resistance (TEER) and TJs expression were obviously increased, and intestinal permeability was evidently decreased. …”
-
197
-
198
A Full-Spectrum ZnS Photocatalyst with Gradient Distribution of Atomic Copper Dopants and Concomitant Sulfur Vacancies for Highly Efficient Hydrogen Evolution
Published 2024“…Through the cooperative action of these atomic Cu dopants and Vs, G-CZS<sub>1–<i>x</i></sub> significantly extends its photoabsorption range to encompass the full spectrum (200–2100 nm), which improves the solar utilization ability. …”
-
199
-
200